A detailed history of Balyasny Asset Management LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 13,600 shares of LNTH stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,600
Previous 17,100 20.47%
Holding current value
$1.22 Million
Previous $1.37 Million 8.75%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$77.7 - $123.62 $25 Million - $39.7 Million
-321,311 Reduced 71.71%
126,735 $13.9 Million
Q2 2024

Aug 14, 2024

BUY
$58.87 - $83.05 $17.1 Million - $24.2 Million
290,907 Added 185.13%
448,046 $36 Million
Q1 2024

May 13, 2024

SELL
$51.07 - $68.26 $32.4 Million - $43.2 Million
-633,510 Reduced 80.13%
157,139 $9.78 Million
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $3.35 Million - $4.69 Million
60,240 Added 8.25%
790,649 $49 Million
Q3 2023

Nov 14, 2023

BUY
$60.27 - $90.75 $18 Million - $27.1 Million
298,758 Added 69.21%
730,409 $50.7 Million
Q2 2023

Aug 14, 2023

BUY
$82.41 - $99.65 $4.44 Million - $5.37 Million
53,887 Added 14.26%
431,651 $36.2 Million
Q1 2023

May 15, 2023

BUY
$47.76 - $82.86 $18 Million - $31.3 Million
377,431 Added 113342.64%
377,764 $31.2 Million
Q4 2022

Feb 14, 2023

BUY
$48.76 - $77.67 $16,237 - $25,864
333 New
333 $16,000
Q2 2020

Aug 14, 2020

SELL
$10.34 - $15.51 $115,270 - $172,905
-11,148 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$9.11 - $20.05 $101,558 - $223,517
11,148 New
11,148 $142,000
Q3 2018

Nov 14, 2018

SELL
$13.1 - $16.35 $281,230 - $351,001
-21,468 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$13.65 - $18.7 $47,775 - $65,450
-3,500 Reduced 14.02%
21,468 $312,000
Q1 2018

May 15, 2018

BUY
$14.85 - $24.3 $370,774 - $606,722
24,968 New
24,968 $397,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.15B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.